Clinical Trial Update: Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating metformin for prevention and intervention of metabolic syndrome in patients initiating androgen deprivation therapy for prostate canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Prostate Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Canadian Urologic Oncology Group | Conditions: Prostate Cancer, Metabolic Syndrome | Phase 3 | Status: TERMINATED